Skip to content

Drug interactions

Erythromycin lactobionate + Zafirlukast

Severity: Minor

Erythromycin lactobionate and Zafirlukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Zafirlukast is a weak CYP3A4 inhibitor, and the legacy claim of raised erythromycin exposure has little clinical relevance. Erythromycin has in fact been reported to lower zafirlukast levels modestly, so the interaction is of limited importance.

What this interaction means in plain words

Erythromycin lactobionate and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Erythromycin lactobionate belongs to Anti Bacterial; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Possible minor CYP3A4-related pharmacokinetic effects; erythromycin may reduce zafirlukast bioavailability.

What to do

No routine adjustment is needed; monitor asthma control if both drugs are used together.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erythromycin lactobionate and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erythromycin lactobionate with Zafirlukast?

MediHelp rates the interaction as minor. Erythromycin lactobionate and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Zafirlukast is a weak CYP3A4 inhibitor, and the legacy claim of raised erythromycin exposure has little clinical relevance. Erythromycin has in fact been reported to lower zafirlukast levels modestly, so the interaction is of limited importance.

How serious is the interaction between Erythromycin lactobionate and Zafirlukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; monitor asthma control if both drugs are used together.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in